Literature DB >> 27838676

An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011.

Amy E Blain1, Melissa Lewis1, Emily Banerjee2, Kathy Kudish3, Juventila Liko4, Suzanne McGuire5, David Selvage6, James Watt7, Stacey W Martin1, Tami H Skoff1.   

Abstract

BACKGROUND: Infants are at greatest risk for severe pertussis. In 2006, the Advisory Committee on Immunization Practices recommended that adolescents and adults, especially those with infant contact, receive a single dose of Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine). To assess the effectiveness of cocooning, we conducted a case-control evaluation of infant close contacts.
METHODS: Pertussis cases aged <2 months with onset between 1 January 2011 and 31 December 2011 were identified in Emerging Infections Program Network sites. For each case, we recruited 3 controls from birth certificates and interviewed identified adult close contacts (CCs) or parents of CCs aged <18 years. Pertussis vaccination was verified through medical providers and/or immunization registries.
RESULTS: Forty-two cases were enrolled, with 154 matched controls. Around enrolled infants, 859 CCs were identified (600 adult and 259 nonadult). An average of 5.4 CCs was identified per case and 4.1 CCs per control. Five hundred fifty-four (64.5%) CCs were enrolled (371 adult and 183 non-adult CCs); 119 (32.1% of enrolled) adult CCs had received Tdap. The proportion of Tdap-vaccinated adult CCs was similar between cases and controls (P = .89). The 600 identified adult CCs comprised 172 potential cocoons; 71 (41.3%) potential cocoons had all identified adult CCs enrolled. Of these, 9 were fully vaccinated and 43.7% contained no Tdap-vaccinated adults. The proportion of fully vaccinated case (4.8%) and control (10.0%) cocoons was similar (P = .43).
CONCLUSIONS: Low Tdap coverage among adult CCs reinforces the difficulty of implementing the cocooning strategy and the importance of vaccination during pregnancy to prevent infant pertussis. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Tdap; cocooning; pertussis

Mesh:

Substances:

Year:  2016        PMID: 27838676      PMCID: PMC5737012          DOI: 10.1093/cid/ciw528

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Waning immunity to pertussis following 5 doses of DTaP.

Authors:  Sara Y Tartof; Melissa Lewis; Cynthia Kenyon; Karen White; Andrew Osborn; Juventila Liko; Elizabeth Zell; Stacey Martin; Nancy E Messonnier; Thomas A Clark; Tami H Skoff
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

2.  Waning protection after fifth dose of acellular pertussis vaccine in children.

Authors:  Nicola P Klein; Joan Bartlett; Ali Rowhani-Rahbar; Bruce Fireman; Roger Baxter
Journal:  N Engl J Med       Date:  2012-09-13       Impact factor: 91.245

3.  The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia.

Authors:  Dale Carcione; Annette K Regan; Lauren Tracey; Donna B Mak; Robyn Gibbs; Gary K Dowse; Max Bulsara; Paul V Effler
Journal:  Vaccine       Date:  2015-08-29       Impact factor: 3.641

4.  Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Karen R Broder; Margaret M Cortese; John K Iskander; Katrina Kretsinger; Barbara A Slade; Kristin H Brown; Christina M Mijalski; Tejpratap Tiwari; Emily J Weston; Amanda C Cohn; Pamela U Srivastava; John S Moran; Benjamin Schwartz; Trudy V Murphy
Journal:  MMWR Recomm Rep       Date:  2006-03-24

5.  Parental Tdap boosters and infant pertussis: a case-control study.

Authors:  Helen E Quinn; Thomas L Snelling; Andrew Habig; Clayton Chiu; Paula J Spokes; Peter B McIntyre
Journal:  Pediatrics       Date:  2014-09-15       Impact factor: 7.124

6.  Sources of Infant Pertussis Infection in the United States.

Authors:  Tami H Skoff; Cynthia Kenyon; Noelle Cocoros; Juventila Liko; Lisa Miller; Kathy Kudish; Joan Baumbach; Shelley Zansky; Amanda Faulkner; Stacey W Martin
Journal:  Pediatrics       Date:  2015-09-07       Impact factor: 7.124

7.  Infant pertussis: who was the source?

Authors:  Kristine M Bisgard; F Brian Pascual; Kristen R Ehresmann; Claudia A Miller; Christy Cianfrini; Charles E Jennings; Catherine A Rebmann; Julie Gabel; Stephanie L Schauer; Susan M Lett
Journal:  Pediatr Infect Dis J       Date:  2004-11       Impact factor: 2.129

8.  Protecting newborns from pertussis - the challenge of complete cocooning.

Authors:  Pascal Urwyler; Ulrich Heininger
Journal:  BMC Infect Dis       Date:  2014-07-17       Impact factor: 3.090

9.  Noninfluenza vaccination coverage among adults - United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-01       Impact factor: 17.586

10.  Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women--Advisory Committee on Immunization Practices (ACIP), 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586

View more
  8 in total

1.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

2.  Social contact patterns of infants in deciding vaccination strategy: a prospective, cross-sectional, single-centre study.

Authors:  M M Oguz; A D Camurdan; F N Aksakal; M Akcaboy; E Altinel Acoglu
Journal:  Epidemiol Infect       Date:  2018-05-09       Impact factor: 4.434

3.  Emerging Cases of Pertussis Among Early Infants Born to Unvaccinated Mothers, an Infectious Disease Long Absent in Northwestern Greece.

Authors:  Alexandros Makis; Vasileios Grammeniatis; Charis Galati; Panagiota Kostara; Evangelia Petridou; Constantina Gartzonika; Athanasios Pappas; Nikolaos Chaliasos
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-06-20       Impact factor: 2.576

Review 4.  Tetanus-diphtheria-acellular pertussis vaccination for adults: an update.

Authors:  Hyo-Jin Lee; Jung-Hyun Choi
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

5.  Close encounters between infants and household members measured through wearable proximity sensors.

Authors:  Laura Ozella; Francesco Gesualdo; Michele Tizzoni; Caterina Rizzo; Elisabetta Pandolfi; Ilaria Campagna; Alberto Eugenio Tozzi; Ciro Cattuto
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

6.  Attributes influencing parental decision-making to receive the Tdap vaccine to reduce the risk of pertussis transmission to their newborn - outcome of a cross-sectional conjoint experiment in Spain and Italy.

Authors:  Edouard Ledent; Giovanni Gabutti; Esther W de Bekker-Grob; Juan Luis Alcázar Zambrano; Magda Campins Martí; María Teresa Del Hierro Gurruchaga; María José Fernández Cruz; Giuseppe Ferrera; Francesca Fortunato; Pierfederico Torchio; Giorgio Zoppi; Christian Agboton; Walid Kandeil; Federico Marchetti
Journal:  Hum Vaccin Immunother       Date:  2019-04-15       Impact factor: 3.452

7.  Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation.

Authors:  Tami H Skoff; Amy E Blain; James Watt; Karen Scherzinger; Melissa McMahon; Shelley M Zansky; Kathy Kudish; Paul R Cieslak; Melissa Lewis; Nong Shang; Stacey W Martin
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

8.  Strategies to increase uptake of maternal pertussis vaccination.

Authors:  Kavin M Patel; Laia Vazquez Guillamet; Lauren Pischel; Mallory K Ellingson; Azucena Bardají; Saad B Omer
Journal:  Expert Rev Vaccines       Date:  2021-07-21       Impact factor: 5.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.